These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15688363)

  • 1. Human population studies with cytogenetic biomarkers: review of the literature and future prospectives.
    Bonassi S; Ugolini D; Kirsch-Volders M; Strömberg U; Vermeulen R; Tucker JD
    Environ Mol Mutagen; 2005; 45(2-3):258-70. PubMed ID: 15688363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms and micronucleus formation: a review of the literature.
    Iarmarcovai G; Bonassi S; Botta A; Baan RA; Orsière T
    Mutat Res; 2008; 658(3):215-33. PubMed ID: 18037339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic methods in human biomonitoring: principles and uses.
    Mateuca RA; Decordier I; Kirsch-Volders M
    Methods Mol Biol; 2012; 817():305-34. PubMed ID: 22147579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH).
    Hagmar L; Bonassi S; Strömberg U; Brøgger A; Knudsen LE; Norppa H; Reuterwall C
    Cancer Res; 1998 Sep; 58(18):4117-21. PubMed ID: 9751622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study design and statistical analysis of data in human population studies with the micronucleus assay.
    Ceppi M; Gallo F; Bonassi S
    Mutagenesis; 2011 Jan; 26(1):247-52. PubMed ID: 21164209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic biomarkers.
    Norppa H
    IARC Sci Publ; 2004; (157):179-205. PubMed ID: 15055296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome damage and cancer risk in the workplace: the example of cytogenetic surveillance in Croatia.
    Fucić A; Znaor A; Strnad M; van der Hel O; Aleksandrov A; Miskov S; Grah J; Sedlar M; Jazbec AM; Ceppi M; Vermeulen R; Boffetta P; Norppa H; Bonassi S
    Toxicol Lett; 2007 Jul; 172(1-2):4-11. PubMed ID: 17651925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Micronuclei and genetic polymorphisms: from exposure to susceptibility].
    Iarmarcovai G; Botta A; Orsière T
    Ann Biol Clin (Paris); 2007; 65(4):357-63. PubMed ID: 17627915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic in vivo assays in somatic cells.
    Doherty AT; Baumgartner A; Anderson D
    Methods Mol Biol; 2012; 817():271-304. PubMed ID: 22147578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the art survey of the buccal micronucleus assay--a first stage in the HUMN(XL) project initiative.
    Bonassi S; Biasotti B; Kirsch-Volders M; Knasmueller S; Zeiger E; Burgaz S; Bolognesi C; Holland N; Thomas P; Fenech M;
    Mutagenesis; 2009 Jul; 24(4):295-302. PubMed ID: 19477934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal changes: induction, detection methods and applicability in human biomonitoring.
    Mateuca R; Lombaert N; Aka PV; Decordier I; Kirsch-Volders M
    Biochimie; 2006 Nov; 88(11):1515-31. PubMed ID: 16919864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching PubMed for molecular epidemiology studies: the case of chromosome aberrations.
    Ugolini D; Neri M; Knudsen LE; Bonassi S; Merlo DF
    Environ Mol Mutagen; 2006 May; 47(4):227-9. PubMed ID: 16416429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic effects and biotoxicity monitoring of occupational styrene exposure.
    Rueff J; Teixeira JP; Santos LS; Gaspar JF
    Clin Chim Acta; 2009 Jan; 399(1-2):8-23. PubMed ID: 18845133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in risk assessment of asbestos exposure.
    Bhattacharya K; Dopp E; Kakkar P; Jaffery FN; Schiffmann D; Jaurand MC; Rahman I; Rahman Q
    Mutat Res; 2005 Nov; 579(1-2):6-21. PubMed ID: 16112146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of two evaluation methods for the genotoxic effects of environmental heavy metals on normal cells.
    Virag P; Brie I; Postescu ID; Perde-Schrepler M; Fischer-Fodor E; Soritau O; Irimie A; Cernea V
    Toxicol Ind Health; 2009; 25(4-5):253-8. PubMed ID: 19651795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytogenetic assays: chromosomal aberrations and micronucleus tests.
    Mosesso P; Cinelli S; Natarajan AT; Palitti F
    Methods Mol Biol; 2013; 1044():123-46. PubMed ID: 23896874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular epidemiology in occupational medicine: methodological features and impact of individual genetic susceptibility].
    Clonfero E; Ferri GM; Pavanello S
    G Ital Med Lav Ergon; 2003; 25(3):279-84. PubMed ID: 14582238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A molecular epidemiology approach to assessing the genotoxic risk in the production of graphite electrodes: the cytogenetic markers and DNA damage].
    Moretti M; Villarini M; Pasquini R; Fatigoni C; Marcarelli M; Scassellati Sforzolini G
    Ann Ig; 1999; 11(6):473-8. PubMed ID: 10596437
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular and genetic epidemiology].
    Kang DH
    Exp Mol Med; 2001 Apr; 33(1 Suppl):73-82. PubMed ID: 11708327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic assays for monitoring populations exposed to environmental mutagens.
    Au WW; Badary OA; Heo MY
    Occup Med; 2001; 16(2):345-57. PubMed ID: 11319056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.